Literature DB >> 15714426

Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany.

Kirsten Fluegge1, Sven Supper, Anette Siedler, Reinhard Berner.   

Abstract

We report the serotype distribution of invasive group B streptococci (GBS) isolated from 296 infants in Germany. Serotype distribution was as follows: serotype Ia, 15%; Ib, 5%; II, 5%; III, 65%; IV, 1%; and V, 8%. Analysis of serotype according to the source of isolation highlighted the considerable role of serotype III in meningitis in early-onset infection (82%) and late-onset infection (84%). Use of a trivalent GBS vaccine in Germany could theoretically provide protection against 84% and 94% of invasive early-onset and late-onset infections, respectively.

Entities:  

Mesh:

Year:  2005        PMID: 15714426     DOI: 10.1086/427942

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis.

Authors:  Anja Reiss; Johann S Braun; Katja Jäger; Dorette Freyer; Gregor Laube; Christoph Bührer; Ursula Felderhoff-Müser; Christine Stadelmann; Victor Nizet; Joerg R Weber
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

2.  Use of a serotype-specific DNA microarray for identification of group B Streptococcus (Streptococcus agalactiae).

Authors:  Linyan Wen; Quan Wang; Yayue Li; Fanrong Kong; Gwendolyn L Gilbert; Boyang Cao; Lei Wang; Lu Feng
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci).

Authors:  Baharak Afshar; Karen Broughton; Roberta Creti; Antoaneta Decheva; Markus Hufnagel; Paula Kriz; Lotte Lambertsen; Marguerite Lovgren; Pierrette Melin; Graziella Orefici; Claire Poyart; Andreas Radtke; Javier Rodriguez-Granger; Uffe B Skov Sørensen; John Telford; Lea Valinsky; Levantia Zachariadou; Androulla Efstratiou
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

4.  Invasive group B streptococcus (GBS) disease in Norway 1996-2006.

Authors:  H Bergseng; M Rygg; L Bevanger; K Bergh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

Review 5.  Induction and termination of inflammatory signaling in group B streptococcal sepsis.

Authors:  Julia Wennekamp; Philipp Henneke
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

6.  Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.

Authors:  Hsiao-Hui Yang; Samantha J Mascuch; Lawrence C Madoff; Lawrence C Paoletti
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

7.  Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.

Authors:  Giovanni Gherardi; Monica Imperi; Lucilla Baldassarri; Marco Pataracchia; Giovanna Alfarone; Simona Recchia; Graziella Orefici; Giordano Dicuonzo; Roberta Creti
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

8.  Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.

Authors:  Vera Eickel; Barbara Kahl; Beatrice Reinisch; Angelika Dübbers; Peter Küster; Claudia Brandt; Barbara Spellerberg
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

9.  Invasive group B streptococcal infections in infants, France.

Authors:  Claire Poyart; Hélène Réglier-Poupet; Asmaa Tazi; Annick Billoët; Nicolas Dmytruk; Philippe Bidet; Edouard Bingen; Josette Raymond; Patrick Trieu-Cuot
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

10.  Epidemiology of and prenatal molecular distinction between invasive and colonizing group B streptococci in The Netherlands and Taiwan.

Authors:  E van Elzakker; R Yahiaoui; C Visser; P Oostvogel; A Muller; Y-R Ho; J-J Wu; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-03-31       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.